×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 2: Insights from the FDA and Industry on Implementation - Policies, Guidance Documents, Guidelines and Regulations (Part 2)
Session Chair(s)
Twyla Mosey, PharmD
Division Director
FDA, United States
Catherine Gray, PharmD
Director, Office of Prescription Drug Promotion, OMP, CDER
FDA, United States
Session 2: Policies, Guidance, Guidelines and Regulations (Globally) – Insights from the FDA and Industry on Implementation (Part 2)